These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20927698)

  • 21. Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome.
    Favre JD; Allain H; Aubin HJ; Frija-Orvoen E; Gillet C; Lejoyeux M; Payen A; Weber M; Garcia-Acosta S; Kermadi I; Dib M
    Hum Psychopharmacol; 2005 Oct; 20(7):511-9. PubMed ID: 16118830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirtazapine improves alcohol detoxification.
    Liappas J; Paparrigopoulos T; Malitas P; Tzavellas E; Christodoulou G
    J Psychopharmacol; 2004 Mar; 18(1):88-93. PubMed ID: 15107190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol withdrawal seizures.
    Morris JC; Victor M
    Emerg Med Clin North Am; 1987 Nov; 5(4):827-39. PubMed ID: 3665832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signs and symptoms assessment: a guide for the treatment of the alcohol withdrawal syndrome.
    Massman JE; Tipton DM
    J Psychoactive Drugs; 1988; 20(4):443-4. PubMed ID: 3244064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of lorazepam treatment for multiple ethanol withdrawals in mice.
    Becker HC; Veatch LM
    Alcohol Clin Exp Res; 2002 Mar; 26(3):371-80. PubMed ID: 11923591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study with Grandaxin and diazepam in alcohol withdrawal syndrome and gerontopsychiatric diseases.
    Bánki CM
    Ther Hung; 1983; 31(3):120-5. PubMed ID: 6152821
    [No Abstract]   [Full Text] [Related]  

  • 28. Trends in the management of alcohol withdrawal syndrome.
    Newman JP; Terris DJ; Moore M
    Laryngoscope; 1995 Jan; 105(1):1-7. PubMed ID: 7837904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carbamazepine in the treatment of alcohol withdrawal].
    Wolańczyk T; Wojnar M; Cedro A
    Psychiatr Pol; 1997; 31(2):189-96. PubMed ID: 9527664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal.
    Huang MC; Chen CH; Liu HC; Chen CC; Ho CC; Leu SJ
    Alcohol Clin Exp Res; 2011 Jan; 35(1):126-31. PubMed ID: 21039634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of alcohol withdrawal.
    Foy A
    Med J Aust; 1986 Jul; 145(1):24-7. PubMed ID: 3523177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants.
    Wilbur R; Kulik FA
    Am J Hosp Pharm; 1981 Aug; 38(8):1138-43. PubMed ID: 6791497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loading dose diazepam therapy for alcohol withdrawal state.
    Manikant S; Tripathi BM; Chavan BS
    Indian J Med Res; 1993 Aug; 98():170-3. PubMed ID: 8262577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open prospective study of zonisamide in acute bipolar depression.
    Ghaemi SN; Zablotsky B; Filkowski MM; Dunn RT; Pardo TB; Isenstein E; Baldassano CF
    J Clin Psychopharmacol; 2006 Aug; 26(4):385-8. PubMed ID: 16855456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic ethanol abuse related hospitalisation in the Internal Medicine Department of the Specialist Hospital in Biała Podlaska (Poland)].
    Chwaluk P
    Przegl Lek; 2004; 61(4):303-6. PubMed ID: 15521588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.
    Kanba S; Yagi G; Kamijima K; Suzuki T; Tajima O; Otaki J; Arata E; Koshikawa H; Nibuya M; Kinoshita N
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):707-15. PubMed ID: 7938561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
    Tosches WA; Tisdell J
    Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.